The $440 million investment in a new production plant in Brnik brings total planned investment in Slovenia to more than $1.1 ...

Significant knowledge gaps about biosimilars persist among consumers and healthcare professionals, hindering their adoption ...

STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo) are approved by FDA for all indications of PROLIA®</ ...

The Global Biosimilars Market size is projected to be valued at USD 27.20 billion in 2023 and reach USD 76.20 billion by 2030 ...

Biocon Biologics Ltd received UK approval for Vevzuo and Evfraxy, biosimilars of Denosumab. Vevzuo is approved for ...

Apotex Inc. ("Apotex" or the "Company"), the Canadian-based global health company, today announced that Health Canada has ...

Kashiv BioSciences has reported encouraging topline outcomes from the randomised confirmatory trial of the proposed ...

FYB203 has been approved by the US FDA and UK Medicines and Healthcare products Regulatory Agency for the treatment ...

Sunshine Biopharma’s Canadian subsidiary, Nora Pharma launches biosimilar drug, Niopeg: Fort Lauderdale, Florida Friday, July 4, 2025, 14:00 Hrs [IST] Sunshine Biopharma Inc., a ...

MEDIA RELEASE <li /> Investment marks latest step in strategic plan to capture significant part of unprecedented bio ...

Biocon Biologics Receives MHRA UK Approval for Vevzuo® and Evfraxy®, Denosumab Biosimilars Bengaluru, Karnataka, India, July 7, 2025  Biocon Biologics Ltd (BBL), a fully integrated global biosimilars ...